You are here

Clinical Trials: Cord Blood

Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: Pneumostem®;   Biological: normal saline
Sponsor:   Medipost Co Ltd.
Recruiting - verified April 2017
Condition:   Hypoplastic Left Heart Syndrome
Intervention:   Biological: autologous cell-based delivery
Sponsors:   Timothy J. Nelson;   University of Oklahoma;   Children's Hospital of Philadelphia
Recruiting - verified June 2017
Conditions:   GATA2;   Immunodeficiency;   MDS
Interventions:   Procedure: Allogeneic HSC;   Drug: Busulfan Test dose;   Drug: Fludarabine(Fludara, Berlex Laboratories);   Drug: Busulfan (Busulfex);   Drug: Cyclophosphamide(CTX, Cytoxan);   Procedure: Total Body Irradiation (TBI);   Drug: Equine Anti-Thymocyte Globulin
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified January 31, 2017
Conditions:   Aplastic Anemia;   Leukemia;   Myelodysplastic Syndrome (MDS);   Lymphoma
Intervention:   Procedure: Cord Blood Units
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   National Institute of Allergy and Infectious Diseases (NIAID);   National Cord Blood Program, New York Blood Center
Recruiting - verified January 12, 2017
Condition:   Hypoplastic Left Heart Syndrome (HLHS)
Intervention:   Other: Collection of umbilical cord blood
Sponsor:   Mayo Clinic
Recruiting
Conditions:   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions:   Biological: Infusion of one MPC expanded cord unit and one unexpanded cord unit;   Biological: Infusion of two unexpanded cord blood units.
Sponsor:   Mesoblast, Ltd.
Completed
Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: Pneumostem®;   Other: Normal Saline
Sponsor:   Medipost Co Ltd.
Completed - verified April 2017
Condition:   Leukemia
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Alloreactive NK infusion;   Drug: Interleukin-2;   Procedure: Stem Cell Infusion;   Drug: G-CSF;   Drug: Tacrolimus;   Drug: Methotrexate
Sponsors:   M.D. Anderson Cancer Center;   Cancer Prevention Research Institute of Texas;   CML Program Project Grant
Recruiting - verified June 2017
Conditions:   Hematological Malignancies;   Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Intervention:   Drug: NiCord®
Sponsor:   Gamida Cell ltd
Recruiting - verified May 2017
Condition:   Acute Leukemia
Intervention:   Procedure: allogeneic transplant
Sponsor:   Gruppo Italiano Trapianto di Midollo Osseo
Completed - verified August 2017

Pages